JP2007261996A - Acrolein adduct-forming inhibitor, and skin external preparation and food and drink containing the same - Google Patents
Acrolein adduct-forming inhibitor, and skin external preparation and food and drink containing the same Download PDFInfo
- Publication number
- JP2007261996A JP2007261996A JP2006089502A JP2006089502A JP2007261996A JP 2007261996 A JP2007261996 A JP 2007261996A JP 2006089502 A JP2006089502 A JP 2006089502A JP 2006089502 A JP2006089502 A JP 2006089502A JP 2007261996 A JP2007261996 A JP 2007261996A
- Authority
- JP
- Japan
- Prior art keywords
- acrolein
- rosaceae
- external preparation
- aging
- fruit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 239000003112 inhibitor Substances 0.000 title claims abstract description 14
- 235000013305 food Nutrition 0.000 title claims abstract description 9
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 19
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 18
- 241000220222 Rosaceae Species 0.000 claims abstract description 18
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 17
- 241000218996 Passiflora Species 0.000 claims abstract description 16
- 244000295519 Chimaphila umbellata Species 0.000 claims abstract description 8
- 235000019120 Chimaphila umbellata Nutrition 0.000 claims abstract description 8
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 8
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 8
- 235000021511 Cinnamomum cassia Nutrition 0.000 claims abstract description 8
- 241000142975 Cornaceae Species 0.000 claims abstract description 8
- 241000208421 Ericaceae Species 0.000 claims abstract description 8
- 241000704033 Euphorbia aggregata Species 0.000 claims abstract description 8
- 241000218195 Lauraceae Species 0.000 claims abstract description 8
- 241000218995 Passifloraceae Species 0.000 claims abstract description 8
- 244000184734 Pyrus japonica Species 0.000 claims abstract description 8
- 240000008530 Rosa canina Species 0.000 claims abstract description 8
- 235000000539 Rosa canina Nutrition 0.000 claims abstract description 8
- 241000759833 Cornus officinalis Species 0.000 claims abstract description 6
- 241001412228 Scaphium lychnophorum Species 0.000 claims abstract description 4
- 235000013399 edible fruits Nutrition 0.000 claims description 16
- 230000003712 anti-aging effect Effects 0.000 claims description 14
- 235000016993 Agrimonia Nutrition 0.000 claims description 10
- 244000307697 Agrimonia eupatoria Species 0.000 claims description 10
- 241000723347 Cinnamomum Species 0.000 claims description 10
- 235000017803 cinnamon Nutrition 0.000 claims description 10
- 235000011925 Passiflora alata Nutrition 0.000 claims description 9
- 235000000370 Passiflora edulis Nutrition 0.000 claims description 9
- 235000011922 Passiflora incarnata Nutrition 0.000 claims description 9
- 235000013750 Passiflora mixta Nutrition 0.000 claims description 9
- 235000013731 Passiflora van volxemii Nutrition 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 8
- 241000221017 Euphorbiaceae Species 0.000 claims description 7
- 241000688197 Pilosa Species 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 4
- 241000254173 Coleoptera Species 0.000 claims description 3
- 235000021028 berry Nutrition 0.000 claims description 3
- 240000008440 Passiflora incarnata Species 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 abstract description 10
- 108090000623 proteins and genes Proteins 0.000 abstract description 10
- 230000032683 aging Effects 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 5
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 4
- 230000037303 wrinkles Effects 0.000 abstract description 4
- 230000009759 skin aging Effects 0.000 abstract description 3
- 241001278836 Agrimonia pilosa Species 0.000 abstract 1
- 235000000641 Agrimonia pilosa Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- VEYYWZRYIYDQJM-ZETCQYMHSA-N N(2)-acetyl-L-lysine Chemical compound CC(=O)N[C@H](C([O-])=O)CCCC[NH3+] VEYYWZRYIYDQJM-ZETCQYMHSA-N 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 241000220317 Rosa Species 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 102100037209 Peroxisomal N(1)-acetyl-spermine/spermidine oxidase Human genes 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 108010089000 polyamine oxidase Proteins 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 244000157072 Hylocereus undatus Species 0.000 description 4
- 235000018481 Hylocereus undatus Nutrition 0.000 description 4
- 241000133222 Lychnophora Species 0.000 description 4
- 241000239226 Scorpiones Species 0.000 description 4
- 241000934878 Sterculia Species 0.000 description 4
- 235000021282 Sterculia Nutrition 0.000 description 4
- -1 acrolein amino acid Chemical class 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000006210 lotion Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 229920000768 polyamine Polymers 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 229940059107 sterculia Drugs 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241000209020 Cornus Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 206010051246 Photodermatosis Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 230000008845 photoaging Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- CHRJZRDFSQHIFI-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;styrene Chemical compound C=CC1=CC=CC=C1.C=CC1=CC=CC=C1C=C CHRJZRDFSQHIFI-UHFFFAOYSA-N 0.000 description 1
- KNUPSOXBESCJLY-UHFFFAOYSA-N 2-methoxy-1-phenylhexan-1-one Chemical compound CCCCC(OC)C(=O)C1=CC=CC=C1 KNUPSOXBESCJLY-UHFFFAOYSA-N 0.000 description 1
- 241001143500 Aceraceae Species 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 206010017865 Gastritis erosive Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 235000013939 Malva Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- DTERQYGMUDWYAZ-ZETCQYMHSA-N N(6)-acetyl-L-lysine Chemical compound CC(=O)NCCCC[C@H]([NH3+])C([O-])=O DTERQYGMUDWYAZ-ZETCQYMHSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 235000005066 Rosa arkansana Nutrition 0.000 description 1
- 241000109365 Rosa arkansana Species 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000000944 Soxhlet extraction Methods 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000008049 biological aging Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008278 cosmetic cream Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- CMFNMSMUKZHDEY-UHFFFAOYSA-N peroxynitrous acid Chemical compound OON=O CMFNMSMUKZHDEY-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000003495 polar organic solvent Substances 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Non-Alcoholic Beverages (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
本発明は、アクロレインのアミノ酸やタンパク質との付加体形成阻害剤であり、その付加体形成阻害剤を含有する皮膚抗老化外用剤や抗老化用飲食品に関する。 The present invention relates to an acrolein amino acid or protein adduct formation inhibitor, and relates to a skin anti-aging external preparation or anti-aging food or drink containing the adduct formation inhibitor.
従来より、老化を抑制する抗老化剤としては、種々のものが開発されている。このような生体の老化は、2つの生物学的要因により起こることが知られている Conventionally, various anti-aging agents that suppress aging have been developed. It is known that such biological aging is caused by two biological factors.
1つは生理的老化で、他の1つは紫外線等の暴露部に生じる光老化皮膚と呼ばれるものである。生理的老化は、生体内で生成した活性酸素が影響し、血管や皮膚の主な構成因子であるコラーゲン線維の変性や生理機能に係わりの深い酵素の変質による活性の低下などに関わる。光老化に感しては、紫外線の暴露が原因であるため皮膚に限られる。 One is physiological aging and the other is called photo-aging skin that occurs in exposed areas such as ultraviolet rays. Physiological aging is influenced by active oxygen generated in the living body, and is related to degeneration of collagen fibers, which are the main components of blood vessels and skin, and a decrease in activity due to alteration of enzymes deeply related to physiological functions. Sensation of photoaging is limited to the skin because it is caused by UV exposure.
生理的老化において、活性酸素種を除去することが主に検討され、スーパーオキサイドアニオン、ヒドロキシラジカル、一重項酸素、パーオキシナイトライト等に対する除去剤が提示されている。近年、活性酸素以外の老化因子としてアクロレインの関与が注目されている。 In physiological aging, removal of reactive oxygen species has been mainly studied, and removal agents for superoxide anion, hydroxy radical, singlet oxygen, peroxynitrite and the like have been proposed. In recent years, the involvement of acrolein as an aging factor other than active oxygen has attracted attention.
アクロレインはα,β-不飽和アルデヒドで反応性が高く、タンパク質(酵素やコラーゲン)の変性や細胞毒性に関わり、その細胞毒性は類縁のアルデヒドであるアセトアルデヒド、ホルムアルデヒド、アクロレインを比較するとアクロレインが最も強く、ホルムアルデヒドそしてアセトアルデヒドである。アクロレインの細胞毒性は、活性酸素の要因となりうる過酸化水素に比べても強いことが報告されている(Kenneth Ramos、etal、Toxicology and Applied Pharmacology、Vol.95、61-71 (1988))。 Acrolein is an α, β-unsaturated aldehyde that is highly reactive and is involved in the denaturation and cytotoxicity of proteins (enzymes and collagen). Formaldehyde and acetaldehyde. It has been reported that the cytotoxicity of acrolein is stronger than hydrogen peroxide, which can be a cause of active oxygen (Kenneth Ramos, etal, Toxicology and Applied Pharmacology, Vol. 95, 61-71 (1988)).
アクロレインは、生体内ではポリアミンから生成したり(Gunnar Houen、etal、Acta Chemia Scandinavica、Vol.48、52-60 (1994))、脂質の過酸化反応の過程で生成する(内田浩二、日本油化学会誌、Vol.47、No.11、29-37(1998))ことがわかっている。また、アクロレインはプラスティックの燃焼、たばこ煙、排気ガスや油脂の加熱によって生成される環境汚染物質の一つである。このように、アクロレインの発生過程は、活性酸素の発生過程とよくオーバーラップしており、今まで老化の原因が活性酸素というのが一般的となっているが、実はアクロレインが関与しているのではないのかとも考えられる。また、アクロレインから生体を守る検討では、ポリアミンにポリアミンオキシダーゼが作用しアクロレインを生成することから、ポリアミンオキシダーゼを阻害する特許(特開2002−281999)とリポキシゲナーゼによる酸化過程でアクロレインが生成することからリポキシゲナーゼを阻害する特許(特開2002−138013)が提示されている。しかし、これらによってアクロレインの生成が完全に抑えられるものではない。
アクロレインから生体を守る検討では、ポリアミンにポリアミンオキシダーゼが作用しアクロレインを生成することから、ポリアミンオキシダーゼを阻害する特許(特開2002−281999)とリポキシゲナーゼによる酸化過程でアクロレインが生成することからリポキシゲナーゼを阻害する特許(特開2002-138013)が提示されている。しかし、これらによってアクロレインの生成が完全に抑えられるものではなく、生成したアクロレインを直接捕捉する作用を持つ成分が望まれている。 In the study of protecting a living body from acrolein, polyamine oxidase acts on polyamine to produce acrolein, so a patent (JP 2002-281999) that inhibits polyamine oxidase and acrolein is produced in the oxidation process by lipoxygenase inhibits lipoxygenase (Japanese Patent Laid-Open No. 2002-138013) is proposed. However, the production of acrolein is not completely suppressed by these, and a component having an action of directly capturing the produced acrolein is desired.
本発明者等は、このような課題を解決するために鋭意研究を重ねた結果、ポリアミンにポリアミンオキシダーゼが作用することによって生成したり、生体内の脂質の過酸化反応により生じた脂質過酸化生成物であるアクロレインが、生体内のタンパク質との付加体形成を阻害することで本発明を完成するに至った。そして、これらを配合する皮膚外用剤に関しては、皮膚のシワ・タルミなどの皮膚老化を、飲食品に関しては動脈硬化などを改善することが期待できる。 As a result of intensive studies to solve such problems, the present inventors have produced lipid peroxidation produced by the action of polyamine oxidase on polyamine or by peroxidation of lipids in vivo. The acrolein, which is a product, has completed the present invention by inhibiting adduct formation with proteins in the living body. And about the skin external preparation which mix | blends these, it can anticipate improving skin aging, such as skin wrinkles and tarmi, and arteriosclerosis etc. about food-drinks.
本発明におけるアクロレインを直接捕捉する方法は、内田らのアセチルリジンとアクロレインの付加生成物をHPLCで測定する方法(J.Biol.Chem.、Vol.273、No.26、Issue of June26、16058-16066(1998))を改変して行った。 The method of directly capturing acrolein in the present invention is a method of measuring an addition product of acetyllysine and acrolein by Uchida et al. (J. Biol. Chem., Vol. 273, No. 26, Issue of June 26, 16058- 16066 (1998)).
すなわち、0.1Mリン酸緩衝液(pH7.4)に100mMのN-アセチルリジンを溶解し、同様に0.1Mリン酸緩衝液(pH7.4)に10mMのアクロレインを溶解し、それぞれ450μLずつ取り、37℃で24時間反応させる。そこに被検試料を100μL加えて、反応液をHPLCで分析し、アクロレインとN-アセチルリジンの付加生成物を分析し、その生成量から抑制率を算出する。 Specifically, 100 mM N-acetyllysine was dissolved in 0.1 M phosphate buffer (pH 7.4), 10 mM acrolein was dissolved in 0.1 M phosphate buffer (pH 7.4), and 450 μL each was taken. Incubate at 37 ° C for 24 hours. 100 μL of a test sample is added thereto, the reaction solution is analyzed by HPLC, the addition product of acrolein and N-acetyllysine is analyzed, and the inhibition rate is calculated from the amount of the product.
本発明における被検試料は、アクロレインがタンパク質との付加体を生成する過程を抑制するアクロレイン付加体生成抑制剤であり、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種を含有させたことを特徴とする。
The test sample in the present invention is an acrolein adduct formation inhibitor that suppresses the process of acrolein forming an adduct with a protein. Passion flower (Passiflora incatnata L (Passifloraceae)) whole plant, Sanshuyu (Cornus
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)) and at least one extract of Cinnamomum cassia (Lauraceae).
また、本発明は、このようなパッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種または二種以上を含有させた皮膚抗老化外用剤および抗老化用飲食品である。
In addition, the present invention provides a whole plant of such passionflower (Passiflora incatnata L (Passifloraceae)), sanshuyu (Cornus
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)), cinnamon flower (Cinnamomum cassia (Lauraceae)) extract containing at least one or two or more skin anti-aging agents and anti-aging foods and drinks.
本発明によれば、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物を含有した安全であり、生体内で生成したアクロレインがタンパク質と付加体を形成する反応を抑えることによるアクロレイン不加体形成抑制剤を含有する皮膚抗老化外用剤および抗老化用飲食品であり、皮膚抗老化外用剤に関してはシワ、タルミ等の発生を抑制することを図り、抗老化用飲食品に関しては生体中の動脈硬化を抑制することが可能となる。
According to the present invention, the whole passionflower (Passiflora incatnata L (Passifloraceae)), sanshuyu (Cornus)
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
pilosa var. japonica (Rosaceae)) whole plant, cinnamon flower (Cinnamomum cassia (Lauraceae)) extract, safe and acrolein produced in vivo suppresses the reaction to form proteins and adducts It is a skin anti-aging external preparation and anti-aging food / beverage products containing an acrolein non-adduct formation inhibitor. With regard to skin anti-aging external preparations, it is intended to suppress the occurrence of wrinkles, tarmi, etc. Can suppress arteriosclerosis in the living body.
本発明に使用する「パッションフラワー」は、薬草として利用されるのは主にincarnata種(チャボトケイソウ)、edulis種(クダモノトケイソウ)の葉、蔓、幹の部分で、主な成分として、多糖体とアルカノイド類を含むフラボノイドに分けられる。研究の結果、このどちらかの成分を単独に使用した場合には鎮静効果は発揮せず、両成分が組み合わさった状態にのみ鎮静効果が確認されたということが報告されている。また、子供に対しても安全に利用できることから、興奮状態の子供を落ち着けるのにも利用されている。 The “passion flower” used in the present invention is mainly used as a medicinal herb in the leaves, vines, and trunks of incarnata species (Chatobodia) and edulis species (Polydiaceae). And flavonoids containing arkanoids. As a result of research, it has been reported that when either of these components is used alone, the sedative effect was not exhibited, and the sedative effect was confirmed only in a state where both components were combined. Moreover, since it can be safely used for children, it is also used to calm excited children.
本発明に使用する「竜珠果」は、Euphorbisは乳液を薬用に用いたと言われている。乳白色の樹液(乳液)は有毒で、刺激性の皮膚炎を起こすことがある。乳液は乳細胞から分泌されるが、乳細胞は乳管という組織を作っている。 As for "Ryuju" used in the present invention, Euphorbis is said to have used an emulsion for medicinal purposes. Milky white sap (milky lotion) is toxic and may cause irritating dermatitis. Milk is secreted from milk cells, which make up a tissue called the duct.
本発明に使用する「MAKJONG」は、Malva nutsとも呼ばれ、東南アジアで果実は食用とされる。コレステロールを抑え、ダイエットなどの作用があるとされる。 “MAKJONG” used in the present invention is also called Malva nuts, and fruits are edible in Southeast Asia. It suppresses cholesterol and is said to have effects such as diet.
本発明に使用する「ローズヒップ」は、ヨーロッパの野ばらの実である。このローズヒップには、レモンの20倍といわれるビタミンCをはじめ、A、B、E、リコピンなども含まれている。 The “rose hip” used in the present invention is a fruit of European wild roses. This rose hip contains vitamin C, which is said to be 20 times that of lemon, as well as A, B, E, and lycopene.
本発明に使用する「オオウメガサソウ」とは、北アメリカのケベック州からジョウジア州とヨーロッパ、日本では茨城県以北の太平洋側、北海道に分布し、アメリカインディアンの間に広く愛用され膀胱結石の薬用に供されている。 "Omegasasou" used in the present invention is distributed from Quebec to North America and Europe in North America, in the Pacific side north of Ibaraki Prefecture in Japan, in Hokkaido, and is widely used by American Indians for medicinal use of bladder stones It is offered to.
本発明に使用する「キンミズヒキ」とは、バラ科ミズヒキ属で、夏に黄花の小花を細長く穂のように咲かせる姿から「金色の水引」に見たてこの名前がついた。全草のエキスは、血小板増加による血液凝固促進と止血作用がありますので、強壮収斂(しゅうれん)止血剤とされていて、喀血(かっけつ)、血便、子宮出血などの止血に用いる。また、抗菌、消炎、鎮痛作用もあり、健胃、下痢止めにも応用される。 The term “Kinzuhiki” used in the present invention is a genus of the family Rosaceae belonging to the family Rosaceae, and is named after “Golden Mizuhiki” in the form of a long and narrow yellow floret that blooms like a spike in summer. Whole herbal extract has a blood coagulation promotion and hemostasis effect due to increased platelets, so it is regarded as a tonic hemostatic agent and used for hemostasis such as hemoptysis, bloody stool, and uterine bleeding. It also has antibacterial, anti-inflammatory and analgesic effects, and can be applied to prevent stomach upset and diarrhea.
本発明に使用する「桂皮花」とは、桂皮で知られるクスノキ科の肉桂の花である。肉桂香辛料や漢方に使用され、薬理作用は鎮静、血圧下降、末梢血管拡張、心臓収縮力増強、ストレス性胃びらん予防効果、胆汁分泌促進、また抗アレルギー、抗炎症、活性酸素産生の抑制などがある。しかし、その花の利用はあまり知られていない。 The “cinnamon flower” used in the present invention is a cinnamon flower of the family Aceraceae known as cinnamon. Used in meat spices and Chinese medicines, pharmacological effects include sedation, blood pressure lowering, peripheral vasodilation, cardiac contraction enhancement, stress gastric erosion prevention effect, promotion of bile secretion, antiallergy, antiinflammation, suppression of active oxygen production, etc. is there. However, the use of that flower is not well known.
即ち、本発明に係る抽出物は、抽出溶媒としては、各種極性有機溶媒及びそれらの混液を用いることができる。抽出物の生成は、様々な方法が用いられるが、各種活性炭、スチレン−ジビニルベンゼン系合成吸着剤(HP−20:三菱化成社製)やオクタデシルシラン処理シリカ(Chromatorex ODS:富士シリシア化学製)により吸着させ、適当な溶媒で溶出する方法が簡便でかつ実用的である。 That is, the extract according to the present invention can use various polar organic solvents and a mixture thereof as the extraction solvent. Various methods are used for the production of the extract. Depending on various activated carbons, styrene-divinylbenzene synthetic adsorbent (HP-20: manufactured by Mitsubishi Kasei Co., Ltd.) and octadecylsilane-treated silica (Chromatorex ODS: manufactured by Fuji Silysia Chemical). The method of adsorbing and eluting with an appropriate solvent is simple and practical.
また、本発明に係る抽出物の各種皮膚外用剤に対する配合量は、皮膚外用剤の実施態様、皮膚外用剤の使用形態等に応じて変動させることができるので特に限定されない。原則的には、有効量存在すれば良いことになるが、一般的には組成物中、乾燥重量に換算して0.0001〜100質量%が利用でき、好ましくは0.01〜10質量%、更に好ましくは0.1〜5.0質量%である。特に、用時調製のパウダー状の製剤等は、この本願発明に係る抽出物が100質量%を含めた高配合率で利用されることが想定できる。 Moreover, since the compounding quantity with respect to the various skin external preparation of the extract which concerns on this invention can be fluctuate | varied according to the embodiment of a skin external preparation, the usage form of a skin external preparation, etc., it is not specifically limited. In principle, an effective amount may be present, but generally 0.0001 to 100% by mass in terms of dry weight can be used in the composition, preferably 0.01 to 10% by mass. More preferably, it is 0.1-5.0 mass%. In particular, it can be assumed that the powdery preparation prepared at the time of use is used at a high blending rate including 100% by mass of the extract according to the present invention.
本発明に係る皮膚外用剤の適用範囲は、特に限定されない。つまり、この発明の有効成分が有する作用効果に応じて各作用効果を利用できる全ての皮膚外用剤に適用できる。 The application range of the external preparation for skin according to the present invention is not particularly limited. That is, the present invention can be applied to all external preparations for skin that can use each function and effect according to the function and effect of the active ingredient of the present invention.
例えば、本発明に係る有効成分を各種皮膚外用剤基剤等に配合して、クリーム、乳液、化粧水、パック剤、洗顔料等に対して適用できる。また、前記各種皮膚外用剤の実施態様は、ローション、エマルジョン、軟膏、ゾル、ゲル、パウダー、スプレー、固形等の各種態様で適用できる。 For example, the active ingredient according to the present invention can be blended in various skin external preparation bases and applied to creams, emulsions, lotions, packs, face wash, and the like. Moreover, the various skin external preparations can be applied in various forms such as lotion, emulsion, ointment, sol, gel, powder, spray, and solid.
また、本発明に係る抗老化用飲食品は、ドリンク剤、ジェル状、粉末製剤、錠剤等の剤型にすることが可能である。 Moreover, the anti-aging food / beverage products according to the present invention can be made into dosage forms such as drinks, gels, powder formulations, tablets and the like.
以下、実施例により本発明を詳細に説明するが、本発明はこれらに限定されるものではない。 EXAMPLES Hereinafter, although an Example demonstrates this invention in detail, this invention is not limited to these.
本実施例は、本発明のアクロレインのタンパク質との付加体形成阻害剤について、具体的な抽出例を示したものである。 This example shows a specific extraction example of the adduct formation inhibitor with the acrolein protein of the present invention.
被検体としては、パッションフラワー(Passiflora incatnata L(Passifloraceae))の全草、サンシュユ(Cornus
officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia
lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))を用いた。
The subjects included passionflower (Passiflora incatnata L (Passifloraceae)), Sanshuyu (Cornus)
officinalis (Cornaceae)) fruit, dragon fruit (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia)
lychnophora fruit, rose hips (Rosa canina (Rosaceae)), giant scorpion (Chimaphila umbellata L. (Pyrolaceae)), red-eared ground (Agrimonia)
The whole plant of pilosa var. japonica (Rosaceae)) and cinnamon flowers (Cinnamomum cassia (Lauraceae)) were used.
上記、抽出物の抽出法は、水であれば、60℃で数時間抽出し得ることができる。エタノール抽出であれば、ソックスレー抽出を行うことによって得ることができる。 The extraction method for the extract can be extracted at 60 ° C. for several hours if it is water. If it is ethanol extraction, it can be obtained by performing Soxhlet extraction.
本実施例は、本発明のアクロレインのタンパク質との付加体形成阻害剤について、抑制率を試験したものである。 In this example, the inhibition rate of the acrolein protein adduct formation inhibitor of the present invention was tested.
〔実験例3〕アクロレインとN-アセチルリジンの付加体形成阻害率の測定
(1)実験方法
50mM N-アセチルリジン450μL(50mMPBS(pH7.4))、10mMアクロレイン450μL(50mMPBS(pH7.4))、試料100μLを混合し、37℃で24時間放置後、HPLCで分析を行った。陽性対照として、類似の反応と思われる糖とアミノ酸やタンパク質と起こるメイラード反応の阻害剤としてとして知られるアミノグアニジンを用いて比較を行った。試料濃度は1%の溶液を用いて行った。
[Experimental Example 3] Measurement of adduct formation inhibition rate of acrolein and N-acetyllysine (1) Experimental method
450 μL of 50 mM N-acetyllysine (50 mM PBS (pH 7.4)), 450 μL of 10 mM acrolein (50 mM PBS (pH 7.4)), and 100 μL of the sample were mixed, left at 37 ° C. for 24 hours, and then analyzed by HPLC. As a positive control, a comparison was made using aminoguanidine, which is known as an inhibitor of the Maillard reaction that occurs with sugars and amino acids and proteins that appear to be similar reactions. The sample concentration was 1%.
(2)HPLC条件
カラム:DAISOPAK-SP120
ODS-BP(150mm×6mm)
温度:室温
移動相:5%MeOH in 0.1%TFA
検出:UV227nm
注入量:5μL
流量:1.5mL/min
(2) HPLC condition column: DAISOPAK-SP120
ODS-BP (150mm × 6mm)
Temperature: Room temperature Mobile phase: 5% MeOH in 0.1% TFA
Detection: UV227nm
Injection volume: 5μL
Flow rate: 1.5mL / min
水抽出物のアクロレイン付加体形成阻害作用を表1に、エタノール抽出物のアクロレイン付加体形成阻害作用を表2に示す。 Table 1 shows the acrolein adduct formation inhibitory action of the water extract, and Table 2 shows the acrolein adduct formation inhibitory action of the ethanol extract.
表1の結果より、パッションフラワー(Passiflora
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物にアクロレインとN-アセチルリジンとの付加体の形成を阻害する作用が強いことを確認した。
From the results in Table 1, passion flower (Passiflora
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
pilosa var. japonica (Rosaceae)) and cinnamon flower (Cinnamomum cassia (Lauraceae)) extracts were confirmed to have a strong inhibitory effect on the formation of adducts of acrolein and N-acetyllysine.
以下に本発明の処方例を挙げる。 The formulation example of this invention is given to the following.
<処方例1>化粧水
(成分名) (質量%)
パッションフラワー水抽出物 0.0001
グリセリン 5.0
ポリオキシエチレンソルビタンモノラウレート(20E.0) 1.5
エタノール 8.0
クエン酸トリエチル 2.0
防腐剤・酸化防止剤 適量
精製水 残部
<Formulation example 1> lotion (component name) (mass%)
Passion flower water extract 0.0001
Glycerin 5.0
Polyoxyethylene sorbitan monolaurate (20E.0) 1.5
Ethanol 8.0
Triethyl citrate 2.0
Preservative / Antioxidant
Purified water balance
<処方例2>化粧用クリーム
(成分名) (質量%)
サンシュユエタノール抽出物 1.0
ミツロウ 2.0
ステアリルアルコール 5.0
ステアリン酸 8.0
スクワラン 10.0
自己乳化型グリセリルモノステアレート 3.0
ポリオキシエチレンセチルエーテル(20E.0) 1.0
グリセリン 5.0
水酸化カリウム 0.3
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Formulation example 2> Cosmetic cream (component name) (mass%)
Sanshuyu ethanol extract 1.0
Beeswax 2.0
Stearyl alcohol 5.0
Stearic acid 8.0
Squalane 10.0
Self-emulsifying glyceryl monostearate 3.0
Polyoxyethylene cetyl ether (20E.0) 1.0
Glycerin 5.0
Potassium hydroxide 0.3
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例3>乳液
(成分名) (質量%)
竜珠果水抽出物 5.0
スクワラン 8.0
ワセリン 2.0
ミツロウ 0.5
ソルビタンセスキオレエート 0.8
ポリオキシエチレンオレイルエーテル(20E.0) 1.2
カルボキシビニルポリマー 0.2
グリセリン 1.5
水酸化カリウム 0.1
エタノール 7.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 3> Emulsion (component name) (mass%)
Dragon Juice Extract 5.0
Squalane 8.0
Vaseline 2.0
Beeslow 0.5
Sorbitan sesquioleate 0.8
Polyoxyethylene oleyl ether (20E.0) 1.2
Carboxyvinyl polymer 0.2
Glycerin 1.5
Potassium hydroxide 0.1
Ethanol 7.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例4>パック剤
(成分名) (質量%)
ローズヒップ水抽出物 0.001
酢酸ビニル樹脂エマルジョン 15.0
ポリビニルアルコール 10.0
ホホバ油 3.0
グリセリン 5.0
酸化チタン 8.0
カオリン 7.0
エタノール 5.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 4> Packing agent (component name) (mass%)
Rosehip water extract 0.001
Vinyl acetate resin emulsion 15.0
Polyvinyl alcohol 10.0
Jojoba oil 3.0
Glycerin 5.0
Titanium oxide 8.0
Kaolin 7.0
Ethanol 5.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例5>軟膏
(成分名) (質量%)
ローズヒップエタノール抽出物 0.01
酢酸トコフェロール 0.5
パラジメチルアミノ安息香酸オクチル 4.0
ブチルメトキシベンゾイルメタン 4.0
ステアリルアルコール 18.0
モクロウ 20.0
グリセリンモノステアリン酸エステル 0.3
ワセリン 33.0
香料 適量
防腐剤・酸化防止剤 適量
精製水 残部
<Prescription Example 5> Ointment (component name) (mass%)
Rosehip ethanol extract 0.01
Tocopherol acetate 0.5
Octyl paradimethylaminobenzoate 4.0
Butylmethoxybenzoylmethane 4.0
Stearyl alcohol 18.0
Owl 20.0
Glycerin monostearate 0.3
Vaseline 33.0
Perfume Appropriate amount of preservative / antioxidant Appropriate amount of purified water
<処方例6>ドリンク剤
サンシュユ水抽出物 10.0
クエン酸 0.1
ビタミンC 適量
精製水 残部
<Formulation Example 6> Drink agent sanshuyu water extract 10.0
Citric acid 0.1
Vitamin C appropriate amount purified water balance
<処方例7>粉末製剤
桂皮花水抽出物 80.0
卵殻カルシウム 10.0
乳糖 5.0
セルロース
残部
<Prescription Example 7> Powder preparation Cinnamon flower water extract 80.0
Eggshell calcium 10.0
Lactose 5.0
cellulose
The rest
<処方例8>錠剤
キンミズヒキ水抽出物 10.0
卵殻カルシウム 10.0
乳糖 20.0
澱粉 7.0
デキストリン 8.0
硬化油 5.0
セルロース
残部
<Prescription Example 8> Tablet Kinmizuki Water Extract 10.0
Eggshell calcium 10.0
Lactose 20.0
Starch 7.0
Dextrin 8.0
Hardened oil 5.0
cellulose
The rest
本発明によれば、パッションフラワー(Passiflora
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物を含有した安全であり、生体内で生成したアクロレインがタンパク質と付加体を形成する反応を抑えることによるアクロレイン不加体形成抑制剤を含有する皮膚抗老化外用剤および抗老化用飲食品であり、皮膚抗老化外用剤に関してはシワ、タルミ等の発生を抑制することを図り、抗老化用飲食品に関しては生体中の動脈硬化を抑制することが可能となる。
According to the present invention, passion flower (Passiflora)
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
pilosa var. japonica (Rosaceae)) whole plant, cinnamon flower (Cinnamomum cassia (Lauraceae)) extract, safe and acrolein produced in vivo suppresses the reaction to form proteins and adducts It is a skin anti-aging external preparation and anti-aging food / beverage products containing an acrolein non-adduct formation inhibitor. With regard to skin anti-aging external preparations, it is intended to suppress the occurrence of wrinkles, tarmi, etc. Can suppress arteriosclerosis in the living body.
Claims (3)
incatnata L(Passifloraceae))の全草、サンシュユ(Cornus officinalis(Cornaceae))の果実、竜珠果(Euphorbia aggregata(Euphorbiaceae))、MAKJONG(Sterculia lychnophora)の果実、ローズヒップ(Rosa canina(Rosaceae))、オオウメガサソウ(Chimaphila umbellata L.(Pyrolaceae))、キンミズヒキ(Agrimonia
pilosa var. japonica(Rosaceae))の全草、桂皮花(Cinnamomum cassia(Lauraceae))の抽出物の少なくとも一種を含有することを特徴とするアクロレイン付加体形成阻害剤。 Passion flower (Passiflora
incatnata L (Passifloraceae) whole plant, Sunshuyu (Cornus officinalis (Cornaceae)) fruit, dragon berries (Euphorbia aggregata (Euphorbiaceae)), MAKJONG (Sterculia lychnophora) fruit, Rosehip (Rosa canina (Rosaceae)), Giant beetle (Chimaphila umbellata L. (Pyrolaceae)), Agrimonia (Agrimonia)
An acrolein adduct formation inhibitor characterized by containing at least one extract of pilosa var. japonica (Rosaceae)) and cinnamon flowers (Cinnamomum cassia (Lauraceae)).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006089502A JP5039314B2 (en) | 2006-03-28 | 2006-03-28 | Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006089502A JP5039314B2 (en) | 2006-03-28 | 2006-03-28 | Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2007261996A true JP2007261996A (en) | 2007-10-11 |
JP5039314B2 JP5039314B2 (en) | 2012-10-03 |
Family
ID=38635341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006089502A Active JP5039314B2 (en) | 2006-03-28 | 2006-03-28 | Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5039314B2 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010029973A1 (en) * | 2008-09-12 | 2010-03-18 | 丸善製薬株式会社 | Skin-whitening agent, anti-aging agent, and skin cosmetic |
JP2010143862A (en) * | 2008-12-19 | 2010-07-01 | Sunstar Inc | Composition containing plant extract |
EP2269621A4 (en) * | 2008-03-31 | 2012-02-22 | Shiseido Co Ltd | Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
WO2012050162A1 (en) * | 2010-10-15 | 2012-04-19 | 株式会社資生堂 | Cellular life span extending agent, and telomerase activator |
JP2013213015A (en) * | 2012-04-04 | 2013-10-17 | Morishita Jintan Co Ltd | Tie2 activating agent |
Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10226617A (en) * | 1997-02-18 | 1998-08-25 | Kao Corp | Skin preparation for external use |
JP2002138013A (en) * | 2000-10-27 | 2002-05-14 | Pias Arise Kk | Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use |
JP2002332224A (en) * | 2001-03-06 | 2002-11-22 | Kose Corp | Anti-ageing skin care preparation and anti-ageing skin care preparation composition |
JP2003034631A (en) * | 2001-07-17 | 2003-02-07 | Koei Kogyo Kk | Fibroblast proliferation-promoting agent and aging- preventing cosmetics |
JP2003048812A (en) * | 2001-07-31 | 2003-02-21 | Koei Kogyo Kk | Elastase inhibitor and antiaging cosmetic |
JP2003201214A (en) * | 2001-10-23 | 2003-07-18 | Shiseido Co Ltd | Matrix metalloprotease activity inhibitor |
JP2004067590A (en) * | 2002-08-06 | 2004-03-04 | Naris Cosmetics Co Ltd | Female sex hormone production promoter and skin preparation for external use containing the same |
JP2004149729A (en) * | 2002-10-31 | 2004-05-27 | Ikeda Shokken Kk | Antioxidant |
JP2004189663A (en) * | 2002-12-11 | 2004-07-08 | Ichimaru Pharcos Co Ltd | Maillard reaction inhibitor |
JP2005008539A (en) * | 2003-06-17 | 2005-01-13 | Fancl Corp | Matrix metalloproteinase inhibitor |
JP2005029556A (en) * | 2002-10-31 | 2005-02-03 | Ikeda Shokken Kk | Skin aging-preventing agent |
JP2006160630A (en) * | 2004-12-03 | 2006-06-22 | Naris Cosmetics Co Ltd | Acrolein adduct formation inhibitor, external preparation for skin containing the same, and healthy supplement food |
JP2006273810A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Inhibitor against acrolein adduct formation, external preparation for skin and health supplement containing the same |
JP2007517883A (en) * | 2004-01-07 | 2007-07-05 | イーエルシー マネージメント エルエルシー | Cosmetic composition containing protein and enzyme inhibitors |
-
2006
- 2006-03-28 JP JP2006089502A patent/JP5039314B2/en active Active
Patent Citations (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10226617A (en) * | 1997-02-18 | 1998-08-25 | Kao Corp | Skin preparation for external use |
JP2002138013A (en) * | 2000-10-27 | 2002-05-14 | Pias Arise Kk | Hne-and-acrolein formation inhibiting and hne-and- acrolein decomposition promoting agent, and skin aging care preparation for external use |
JP2002332224A (en) * | 2001-03-06 | 2002-11-22 | Kose Corp | Anti-ageing skin care preparation and anti-ageing skin care preparation composition |
JP2003034631A (en) * | 2001-07-17 | 2003-02-07 | Koei Kogyo Kk | Fibroblast proliferation-promoting agent and aging- preventing cosmetics |
JP2003048812A (en) * | 2001-07-31 | 2003-02-21 | Koei Kogyo Kk | Elastase inhibitor and antiaging cosmetic |
JP2003201214A (en) * | 2001-10-23 | 2003-07-18 | Shiseido Co Ltd | Matrix metalloprotease activity inhibitor |
JP2004067590A (en) * | 2002-08-06 | 2004-03-04 | Naris Cosmetics Co Ltd | Female sex hormone production promoter and skin preparation for external use containing the same |
JP2004149729A (en) * | 2002-10-31 | 2004-05-27 | Ikeda Shokken Kk | Antioxidant |
JP2005029556A (en) * | 2002-10-31 | 2005-02-03 | Ikeda Shokken Kk | Skin aging-preventing agent |
JP2004189663A (en) * | 2002-12-11 | 2004-07-08 | Ichimaru Pharcos Co Ltd | Maillard reaction inhibitor |
JP2005008539A (en) * | 2003-06-17 | 2005-01-13 | Fancl Corp | Matrix metalloproteinase inhibitor |
JP2007517883A (en) * | 2004-01-07 | 2007-07-05 | イーエルシー マネージメント エルエルシー | Cosmetic composition containing protein and enzyme inhibitors |
JP2006160630A (en) * | 2004-12-03 | 2006-06-22 | Naris Cosmetics Co Ltd | Acrolein adduct formation inhibitor, external preparation for skin containing the same, and healthy supplement food |
JP2006273810A (en) * | 2005-03-30 | 2006-10-12 | Naris Cosmetics Co Ltd | Inhibitor against acrolein adduct formation, external preparation for skin and health supplement containing the same |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2269621A4 (en) * | 2008-03-31 | 2012-02-22 | Shiseido Co Ltd | Agents for maturing, normalizing or stabilizing blood vessels and wrinkle-preventing and improving agents |
US9320770B2 (en) | 2008-03-31 | 2016-04-26 | Shiseido Company, Ltd. | Blood vessel maturation, normalization or stabilization agent and wrinkle preventer/improver |
WO2010029973A1 (en) * | 2008-09-12 | 2010-03-18 | 丸善製薬株式会社 | Skin-whitening agent, anti-aging agent, and skin cosmetic |
JP2010065009A (en) * | 2008-09-12 | 2010-03-25 | Maruzen Pharmaceut Co Ltd | Skin brightener and anti-aging agent, and skin cosmetic |
JP2010143862A (en) * | 2008-12-19 | 2010-07-01 | Sunstar Inc | Composition containing plant extract |
WO2012050162A1 (en) * | 2010-10-15 | 2012-04-19 | 株式会社資生堂 | Cellular life span extending agent, and telomerase activator |
JP2013213015A (en) * | 2012-04-04 | 2013-10-17 | Morishita Jintan Co Ltd | Tie2 activating agent |
Also Published As
Publication number | Publication date |
---|---|
JP5039314B2 (en) | 2012-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4033877B2 (en) | Composition for promoting type I collagen production | |
KR101760959B1 (en) | Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same | |
KR101713357B1 (en) | Cosmetic composition for the treatment of acne comprising a peptide extract of schizandra | |
KR20210095741A (en) | Avocado flesh and/or skin extract rich in polyphenols and cosmetic, dermatological and nutraceutical compositions comprising same | |
WO2021104276A1 (en) | Uses of fu tea extract in preparing skin-conditioning product | |
JP7338105B2 (en) | Kapok tree flower extract and cosmetic, pharmaceutical or dermatological composition containing the same | |
JP5063947B2 (en) | Acrolein adduct formation inhibitor, and skin anti-aging external preparation and anti-aging food and drink containing the same | |
JP5039314B2 (en) | Acrolein adduct formation inhibitor, and external preparation for skin and food and drink containing the same | |
JP2006111545A (en) | Glutathione reductase activity-enhancing agent | |
JP5773111B2 (en) | Composition for inhibiting skin pigmentation and use thereof | |
JP2004067590A (en) | Female sex hormone production promoter and skin preparation for external use containing the same | |
JPH10120583A (en) | Antiallergic agent, chemical mediator liberation suppressant and antiallergic cosmetic, medicine and food comprising the sam | |
KR101744889B1 (en) | Composition for Anti-oxidation, Whitening and Wrinkles protection | |
JP2008024601A (en) | Inhibitor for acrolein adduct formation, skin anti-aging external preparation and anti-aging food and beverage containing the same | |
JP4866012B2 (en) | Acrolein adduct formation inhibitor, skin external preparation and health supplement containing the same | |
JP6055667B2 (en) | Collagen production promoter | |
US10143648B2 (en) | Peptide and oside extract of schisandra fruit and improvement in the response of the cutaneous neurosensory system | |
JP4944372B2 (en) | Acrolein adduct formation inhibitor, and skin external preparation and health supplement containing the same | |
KR101914441B1 (en) | Cosmetic compositions for improving skin moisturizing comprising fucosterol | |
KR101904501B1 (en) | Cosmetic compositions for improving skin wrinkles or skin elasticity comprising fucosterol | |
JP5777209B2 (en) | Collagen production promoter and food composition | |
KR101797526B1 (en) | Hair cosmetic composition containing an extract of Dendropanax morbifera ferment | |
JP4247091B2 (en) | Skin anti-aging agent | |
JP2011195530A (en) | Protein glycation inhibitor | |
JP4169814B2 (en) | A topical skin preparation containing agave or sisal extract |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090327 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20111122 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120123 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120420 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120612 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120709 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150713 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5039314 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |